Anti Inflammatory Drugs Market Revenue, Company Profile, Key Trend Analysis & Forecast, 2030
Potential pipeline candidates is a key factor driving anti-inflammatory drugs market revenue growth
Market Size – USD 111.42 Billion in 2021, Market Growth – at a CAGR of 9.3%, Market Trends – Rising prevalence of inflammatory diseases
The Anti Inflammatory Drugs Report conjointly verifies
the market conditions together with the Anti Inflammatory Drugs product value,
specification, Anti Inflammatory
Drugs research methodologies, money and technical
details which is able to facilitate the expansion of the Anti Inflammatory Drugs market operations.
In the Global Anti
Inflammatory Drugs Market Research Report published by Emergen
Research, key business details are analyzed along with a geographical overview
of the Anti Inflammatory Drugs industry, which provides extensive analysis of
this sector. This study provides a comprehensive look at the Anti Inflammatory
Drugs market from both a qualitative and quantitative perspective as well as
crucial statistical information about the market. As of 2017, the research
study provides historical data and offers forecasts up to 2027. Furthermore,
the report describes emerging and established players of the market, providing
an overview of their business, their product portfolio, their strategic
alliances, and their plans for expansion.
In view of the current COVID-19 pandemic, the growth of the
Anti Inflammatory Drugs industry is expected to be significantly affected,
especially due to movement restrictions and lockdowns affecting supply and
demand. There has been a significant impact of the COVID-19 pandemic on several
sectors of the global market. The Anti Inflammatory Drugs sector is expected to
be affected too. The economic slowdown and dynamic changes in the demands will
also adversely affect the growth of the industry. The report covers the impact
analysis of the COVID-19 pandemic on the overall Anti Inflammatory Drugs
industry.
The global anti-inflammatory drugs market size reached USD
111.42 Billion in 2021 and is expected to register a revenue CAGR of 9.3%
during the forecast period, according to latest analysis by Emergen Research.
Potential pipeline candidates is the main factor driving the market revenue
growth. For instance, the monoclonal antibody mirikizumab (LY3074828) fulfilled
the primary and all significant secondary objectives in the LUCENT-1 ulcerative
colitis Phase 3 study, according to a March announcement from Lilly. The drug's
potential as a therapy for moderate to severe ulcerative colitis was assessed
throughout the 12-week multicenter induction phase. The humanized monoclonal
antibody attaches to the interleukin-23 p19 subunit (IL-23p19). A cytokine that
promotes inflammation is interleukin-23. In March, Lilly bragged that the Phase
3 trial LUCENT-1, which used an anti-IL-23p19 monoclonal antibody, was the only
one to show a reduction in bowel urgency in patients with moderate to severe
ulcerative colitis. Mirikizumab can be used to treat ulcerative colitis and
crohn's disease, according to Lilly.
Request Free Sample Copy (To Understand the
Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1299
Market Dynamics:
The report offers insightful information about the market
dynamics of the Anti Inflammatory Drugs market. It offers SWOT analysis, PESTEL
analysis, and Porter’s Five Forces analysis to present a better understanding
of the Anti Inflammatory Drugs market, competitive landscape, factors affecting
it, and to predict the growth of the industry. It also offers the impact of
various market factors along with the effects of the regulatory framework on
the growth of the Anti Inflammatory Drugs market.
Radical Highlights of the Anti Inflammatory Drugs
Market Report:
- Comprehensive
overview of the Anti Inflammatory Drugs market along with analysis of the
changing dynamics of the market
- Growth
Assessment of various market segments throughout the forecast period
- Regional
and global analysis of the market players, including their market share
and global position
- Growth
strategies adopted by key market players to combat the impact of the
COVID-19 pandemic on the market
- Impact
of the technological developments and R&D advancements on the Anti
Inflammatory Drugs market
- Information
about profit-making strategies and developmental strategies of major
companies and manufacturers
- Insightful
information for the new entrants willing to enter the market
- Details
and insights about business expansion strategies, product launches, and
other collaborations
- The
report incorporates advanced analytical tools such as SWOT analysis,
Porter’s Five Forces Analysis, feasibility analysis, and investment return
analysis
Emergen Research is Offering Limited Time Discount
(Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1299
The leading market contenders listed in the report
are:
AbbVie Inc., Johnson & Johnson Private
Limited, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc.,
Novartis AG, GSK plc, Lilly, Amgen Inc., Biogen
Competitive Landscape:
Furthermore, the report includes an in-depth analysis of the
competitive landscape. The segment covers a comprehensive overview of the
company profiles along with product profiles, production capacities,
products/services, pricing analysis, profit margins, and manufacturing process
developments. The report also covers strategic business measures undertaken by
the companies to gain substantial market share. The report provides insightful
information about recent mergers and acquisitions, product launches,
collaborations, joint ventures, partnerships, agreements, and government deals.
Segments Covered in this report are:
- Drug
Class Outlook (Revenue, USD Billion; 2019-2030)
- Anti-Inflammatory
Biologics
- Non-Steroidal
Anti-Inflammatory Drugs (NSAIDs)
- Corticosteroids
- Route
of Administration Outlook (Revenue, USD Billion; 2019-2030)
- Oral
- Injection
- Inhalation
- Topical
Browse Full Report Description + Research
Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/anti-inflammatory-drugs-market
- Application
Outlook (Revenue, USD Billion; 2019-2030)
- Autoimmune
Inflammatory Diseases
- Rheumatoid
Arthritis
- Psoriasis
- Others
- Respiratory
Diseases
- Others
Regional Segmentation;
North America (U.S., Canada)
Europe (U.K., Italy, Germany,
France, Rest of EU)
Asia Pacific (India, Japan,
China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil,
Argentina, Rest of Latin America)
Middle East & Africa (Saudi
Arabia, U.A.E., South Africa, Rest of MEA)
Request Cumtomization as per your specific
requirement@ https://www.emergenresearch.com/request-history/1299
Thank you for reading the report. The report can be customized
as per the requirements of the clients. For further information or query about
customization, please reach out to us, and we will offer you the report best
suited for your needs.
Latest Published Reports by Emergen Research:
Point Of Care Testing Market
https://www.emergenresearch.com/industry-report/point-of-care-testing-market
Biomaterials Market
https://www.emergenresearch.com/industry-report/biomaterials-market
Intelligent Lighting Control Market
https://www.emergenresearch.com/industry-report/intelligent-lighting-control-market
Agricultural Films Market
https://www.emergenresearch.com/industry-report/agricultural-films-market
Smart Irrigation Market
https://www.emergenresearch.com/industry-report/smart-irrigation-market
Brachytherapy Market
https://www.emergenresearch.com/industry-report/brachytherapy-market
Research Antibodies Market
https://www.emergenresearch.com/industry-report/research-antibodies-market
Comments
Post a Comment